CERS Cerus Corp.
4,238
$1.97
$0.01
(0.51%)
| Watchers | 4,238 |
| 52-Wk Low | $1.21 |
| 52-Wk High | $3.08 |
| Market Cap | $362.38M |
| Volume | 259,962.00 |
| 52-Wk High | $3.08 |
| 52-Wk Low | $1.21 |
Cerus Corporation Announces First Quarter 2024 Financial ResultsBusiness Wire • 15 days ago
Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2024. Recent highlights include: First-quarter 2024 total revenue was comprised of (in...
Share to Feed
Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market. The Company will host a...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Cerus Corporation (Nasdaq: CERS) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of 12-month shelf life for INTERCEPT Platelet Processing Sets, from the date of...
Investors eyeing a purchase of Cerus Corp. (CERS) shares, but tentative about paying the going market price of 1.93/share, might benefit from considering selling puts among the alternative...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Cerus Corporation (Nasdaq: CERS) today announced positive topline results for ReCePI, a pivotal Phase 3 clinical trial of pathogen reduced INTERCEPT Red Blood Cells (INTERCEPT RBCs) transfused to...
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Cerus (CERS Research Report), with a price target of $5.00. Jo...
Cerus Co. (NASDAQ:CERS Get Free Report) CEO William Mariner Greenman sold 62,315 shares of Cerus stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price...